Cerebral and Renal Oxymetry and Anesthetic Techniques in Newborns

July 19, 2023 updated by: Antalya Training and Research Hospital

Comparison of the Effects of Anesthetic Techniques Used for Cesarean Delivery on Neonatal Cerebral and Renal Oxygenation

Neonatal adaptation to extrauterine life has many physiological changes in neonatal organ systems. These adaptative changes may be affected such as type of delivery and anesthesia management at birth. near infrared spectroscopy (NIRS) is a popular non-invasive method that can be used in newborns thus monitorize tissue oxygenation regularly. In this study we have purposed to compare the effects of general anesthesia versus spinal anesthesia on newborn's cerebral and renal oxygenation in elective cesarean operations

Study Overview

Detailed Description

The cases divided into two groups those spinal anesthesia group ( group:1; n:30 ) and general anesthesia group (group:2; n:30). The preoperative and intraoperative mean arterial pressures (MAP), heart rate (HR), arterial oxyhemoglobin saturation (SpO2), intraoperative blood loss values of pregnants and 1st-5th minute APGAR scores, preductal and postductal SpO2, perfusion index, heart rates, body temperature, cerebral and renal regional oxygen saturations of newborns after birth have been recorded.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients who undergo elective cesarean
  • American Society of Anesthesiologists class 1 to 2
  • Ability to consent
  • Gestational age: from 37 to 41 weeks

Exclusion Criteria:

  • Pulmonary disease
  • History of allergic reaction to local anaesthetics
  • Peripheral neuropathy
  • Neurologic disease
  • Coagulation disorders
  • newborns with anomalies
  • low birth weight newborns
  • newborns needing neonatal resuscitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: spinal anesthesia
Patients in this group were randomized to receive spinal anesthesia. (Near infrared spectroscopy (spinal anesthesia))
effect of spinal anesthesia on regional renal and cerebral oxygen saturation in newborns
Active Comparator: general anesthesia
Patients in this group were randomized to receive general anesthesia. (Near infrared spectroscopy (general anesthesia)).
effect of general anesthesia on regional renal and cerebral oxygen saturation in newborns

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in renal and cerebral regional oxygenation (rSO2) in newborn
Time Frame: 60 minutes after birth
Assessed at third and fifth minutes and then every 5 minutes after birth
60 minutes after birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
preductal SpO2
Time Frame: 60 minutes after birth
changes in preductal SpO2 after birth
60 minutes after birth
postductal SpO2
Time Frame: 60 minutes after birth
changes in postductal SpO2 after birth
60 minutes after birth
perfusion index
Time Frame: 60 minutes after birth
changes in perfusion index after birth
60 minutes after birth
body temperature
Time Frame: 60 minutes after birth
changes in body temperature after birth
60 minutes after birth
apgar scores
Time Frame: 1st and 5th minute after birth
changes in apgar scores after birth
1st and 5th minute after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ulku Arslan, MD, Antalya Training and Research Hospital
  • Principal Investigator: Nilgun Kavrut Ozturk, MD, Antalya Training and Research Hospital
  • Principal Investigator: Ali Sait Kavakli, MD, Antalya Training and Research Hospital
  • Principal Investigator: Ozge Dagdelen, MD, Antalya Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

August 1, 2017

Study Registration Dates

First Submitted

December 19, 2017

First Submitted That Met QC Criteria

December 26, 2017

First Posted (Actual)

January 3, 2018

Study Record Updates

Last Update Posted (Actual)

July 20, 2023

Last Update Submitted That Met QC Criteria

July 19, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Delivery Affecting Newborn

Clinical Trials on Near infrared spectroscopy (spinal anesthesia)

3
Subscribe